» Articles » PMID: 11883532

Rho GTPases in Transformation and Metastasis

Overview
Journal Adv Cancer Res
Publisher Elsevier
Specialty Oncology
Date 2002 Mar 9
PMID 11883532
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

During the development and progression of human cancer, cells undergo numerous changes in morphology, proliferation, and transcriptional profile. Over the past couple of decades there have been intense efforts to understand the molecular mechanisms involved, and members of the Ras superfamily of small GTPases have emerged as important players. Mutated versions of the Ras genes were first identified in human cancers some 20 years ago, but more recently, the Rho branch of the family has been receiving increased attention. In addition to the experimental evidence implicating Rho GTPase signaling in promoting malignant transformation, genetic analysis of human cancers has now revealed a few examples of direct alterations in the genes encoding regulators of Rho GTPases. In this review, we discuss the evidence implicating Rho GTPases in transformation and metastasis, as well as the progress made toward identifying their biochemical mechanism of action.

Citing Articles

RhoA-ROCK2 signaling possesses complex pathophysiological functions in cancer progression and shows promising therapeutic potential.

Ning Y, Zheng M, Zhang Y, Jiao Y, Wang J, Zhang S Cancer Cell Int. 2024; 24(1):339.

PMID: 39402585 PMC: 11475559. DOI: 10.1186/s12935-024-03519-7.


Severe pantothenic acid deficiency induces alterations in the intestinal mucosal proteome of starter Pekin ducks.

Tang J, Feng Y, Zhang B, Wu Y, Guo Z, Liang S BMC Genomics. 2021; 22(1):491.

PMID: 34193047 PMC: 8246668. DOI: 10.1186/s12864-021-07820-x.


Targeting the cytoskeleton against metastatic dissemination.

Ruggiero C, Lalli E Cancer Metastasis Rev. 2021; 40(1):89-140.

PMID: 33471283 DOI: 10.1007/s10555-020-09936-0.


Frequent Downregulation and Promoter Hypermethylation of DLC1: Relationship with Clinical Outcome in Gallbladder Cancer.

Singh D, Bharti A, Biswas D, Tewari M, Kar A, Ansari M J Gastrointest Cancer. 2021; 53(2):237-244.

PMID: 33417200 DOI: 10.1007/s12029-020-00560-3.


A novel tumor suppressing gene, , is an independent prognostic biomarker for bladder cancer.

Piao X, Jeong P, Yan C, Kim Y, Byun Y, Xu Y Oncol Lett. 2020; 19(1):476-486.

PMID: 31897161 PMC: 6924059. DOI: 10.3892/ol.2019.11123.